Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

There are a multitude of products for sale that promise the appearance of eternal youth by erasing wrinkles or firming up jaw ...

Researchers from Tokyo Metropolitan University have developed a way to treat age-related muscular atrophy using regenerative ...

Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of ...

As a consequence of the transfer of its Jyseleca® business to Alfasigma, the revenues and costs related to Jyseleca® for the full years 2024 and 2023 are presented separately from the results of the ...

Robotic automation is key for automakers adapting to the evolving EV market, allowing for flexible production and efficient ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

The scientists wanted to use the cloned cells to create therapies and life-saving treatments for ... The four sheep cloned from Dolly’s cell line did not suffer the same bad health as their sister, ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...